Search

Your search keyword '"Lund L"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Lund L" Remove constraint Author: "Lund L" Topic medicine.medical_specialty Remove constraint Topic: medicine.medical_specialty
23 results on '"Lund L"'

Search Results

1. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

2. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

3. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

4. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

5. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

6. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

7. Ezetimibe added to statin therapy after acute coronary syndromes

8. Poster session 2: Thursday 4 December 2014, 08:30-12:30Location: Poster area

9. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries

10. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

11. Laparoscopic cecostomy for anterior ectopic anus with constipation: a new and technical proposal

12. Survival of patients with kidney cancer in central and northern Denmark, 1998–2009

13. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

14. Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

15. Heart failure with mid-range or mildly reduced ejection fraction

16. Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

17. Impact of coronavirus disease 2019 (COVID-19) outbreak on acute admissions at the emergency and cardiology departments across Europe

18. Use of sodium-glucose co-transporter 2 inhibitors in patients with heart failure and type 2 diabetes mellitus: data from the Swedish Heart Failure Registry

19. Efficacy and safety of glucagon-like peptide-1 agonists on macrovascular and microvascular events in type 2 diabetes mellitus: A meta-analysis

20. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry

21. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

22. Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial

23. A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure

Catalog

Books, media, physical & digital resources